Aviva PLC Stoke Therapeutics, Inc. Transaction History

Aviva PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 10, 2021	SELL	$30.53 - $41.09 $924,020 - $1.24 Million	-30,266 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$36.08 - $69.81 $234,050 - $452,857	-6,487 Reduced 17.65%	30,266 $1.18 Million
Q4 2020 Feb 10, 2021	SELL	$33.62 - $61.93 $1 Million - $1.85 Million	-29,792 Reduced 44.77%	36,753 $2.28 Million
Q3 2020 Nov 12, 2020	BUY	$22.23 - $37.48 $1.48 Million - $2.49 Million	66,545 New	66,545 $2.23 Million

125

57.6M

9.3K

35.2K

Ticker STOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,419,300
Market Cap $367M
Description
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...

Get notified when there are updates to the investment portfolio of Aviva PLC, based on Form 13F filings with the SEC.

Stay updated on Aviva PLC with notifications on news.